Owc Pharmaceutical Research Corp. (QB)
Ticker Symbol: USOTC:OWCP
OTC Market Tier: OTCQB
CIK Number: 0001431934
Security Type: Common Stock
OWCP Address: 2 Ben Gurion Street
Ramat Gan5257334
OWCP Country: Israel
OWCP Phone: 972-72-260-8004
OWCP Fax #: +972-3-919-3921
Website: http://www.OWCpharma.com
Description: OWC Pharmaceutical Research Corp. is engaged in the business, through its wholly-owned Israeli subsidiary, One Word Cannabis Ltd. ("OWC"), of conducting medical research and clinical trials, in full compliance with all international regulatory protocols, for the development and improvement of strains of medical cannabis specifically designed for the treatment of several illnesses/medical conditions. Under the direction of Dr. Yehuda Baruch, our Director of Research and Regulatory Affairs and Chief Science Officer, the Company has recently filed a patent application with the United States Patent and Trademark Office for its active cannabinoid-based topical cream. OWC has also entered into an agreement with Mediq Innovation Partners for marketing OWC's topical psoriasis cream in Germany. OWC has also progressed on using specific dosages of its Cannabaniod-based products administered through soluble pills taken orally, with its initial focus on PTSD, multiple myeloma and topical treatment of burns in addition to psoriasis. Our business plan includes entering into collaborative ventures with major medical centers and highly regarded researchers in Israel and potentially other countries with the goal of developing novel therapeutic methods for the treatment of serious medical conditions with cannabis-based therapies and are conducting pre-clinical investigations and randomized, placebo-controlled trials of cannabis-based compounds and develop unique, condition-specific products.
SIC Code / Description: 3841 / Surgical and medical instruments
Shares Authorized: 500,000,000
Shares Outstanding: 244,477,874
Shares Outstanding Date: 09/03/2019
Shares Holder Count: 224
Shares Holder Date: 09/09/2019
Market Capitalization: $ 2,122,067.95
Key Executives: Sigal Russo - CFO
Mordechai Bignitz - CEO
Dr. Oron Yacoby Zeevi - Chief Scientific Officer
Dr. Stanley Hirsch - Chairman
Alon Sinai - COO
Yuval Ramot - Consultant
Yehuda Baruch - Chief Med. Officer
Number of Employees: 7
Incorporation State: DE
Incorporation Country: USA
Incorporation Year: 2008
Auditor: Fahn Kanne & Co.
Auditor Address: 23 Menachem Begin St.
Levenstein Tower
24th floor
Tel-Aviv66184
Israel
Auditor Website: N/A
IR Firm: N/A
Legal Counsel: N/A
Fiscal Year End: 12/31
Reporting Status: SEC Reporting
Bankrupt: No
Shell: No
Audit Status: Yes
ADR Ratio: N/A
Transfer Agent: VStock Transfer LLC
TA Address: 18 Lafayette Place
Woodmere, NY 11598
USA
Depository Website: N/A
SHO Flag: N/A
3210 Flag: N/A
Short Volume: 26,010
Short Date: 08/15/2019
Closing MMID: 10
BFCMmid: 8
Tier ID: 10
Status: Active


Your Recent History
USOTC
OWCP
OWC Pharma..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.